Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Marc Bonten, MD, PhD

Julius Center for Health Sciences and Primary Care, University Medical Center, Netherlands

Disclosure(s): Astra-Zeneca: Advisor/Consultant; Janssen: Advisor/Consultant; Merck: Advisor/Consultant; Novartis: Advisor/Consultant

Poster(s):

235 - Tracking Invasive Extraintestinal Pathogenic Escherichia coli Disease in Older Adults in a Community-Based Clinical Trial Setting
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
1130 - Ensovibep antiviral activity in ambulatory patients with COVID-19 is independent of baseline anti-SARS-CoV-2 antibodies and exhibits minimal selective pressure – Results from the placebo-controlled EMPATHY trial
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET
1823 - Clinical Profile and Antimicrobial Susceptibility of Invasive Extraintestinal Pathogenic Escherichia coli Disease in Hospitalized Adults Aged ≥60 Years
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET